Cytochrome P450: Nature's most versatile biological catalyst

Annual Review of Pharmacology and Toxicology

Volumn 45, Issue , 2005, Pages 1-25

  Coon, Minor J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Coupling of reductase and P450 reaction cycles; Oxygen activation to give multiple functional oxidants; Purification and characterization of multiple P450s; Resolution and reconstitution of the microsomal P450 system

Indexed keywords

3 METHYLCHOLANTHRENE; CARBON MONOXIDE; CYTOCHROME P450; ISOPROTEIN; OXIDOREDUCTASE; OXYGENASE; PHENOBARBITAL; PROADIFEN;

CATALYST; CHEMICAL REACTION KINETICS; ENZYME KINETICS; ENZYME MECHANISM; ENZYME PURIFICATION; ENZYME RECONSTITUTION; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE; ENZYME SUBUNIT; HISTORY OF MEDICINE; HUMAN; MICROSOME MEMBRANE; OXIDATION KINETICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REACTION ANALYSIS; REVIEW;

ANIMALS; CATALYSIS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; ISOENZYMES; SUBSTRATE SPECIFICITY;

EID: 13844322067     PISSN: 03621642     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.pharmtox.45.120403.100030     Document Type: Review

References (129)

1. Coon MJ. 2002. Enzyme ingenuity in biological oxidations: a trail leading to cytochrome P450. J. Biol. Chem. 277: 28351-63
2. Coon MJ, Gurin S. 1949. Studies on the conversion of radioactive leucine to acetoacetate. J. Biol. Chem. 180:1159-67
3. Coon MJ. 1950. The metabolic fate of the isopropyl group of leucine. J. Biol. Chem. 187:71-82
4. Bachhawat BK, Robinson WG, Coon MJ. 1954. Carbon dioxide fixation in heart extracts by β-hydroxyisovaleryl coenzyme A. J. Am. Chem. Soc. 76:3098
5. del Campillo-Campbell A, Dekker EE, Coon MJ. 1959. Carboxylation of β-methylcrotonyl coenzyme A by a purified enzyme from chicken liver. Biochim. Biophys. Acta 31:290-92
6. Coon MJ, Kupiecki FP, Dekker EE, Schlesinger MJ, del Campillo A. 1959. The enzymic synthesis of branched-chain acids. In Ciba Foundation Symposium on the Biosynthesis of Terpenes and Sterols, ed. GEW Wolstenholme, M O'Connor, pp. 62-72. London: J & A Churchill
7. Duller H, Coon MJ, Kull A, Vogel H, Waldvogel G, Prelog V. 1971. Fatty acid synthetase from pig liver. 1. Isolation of the enzyme complex and characterization of the component with oxidoreductase activity for alicyclic ketones. Eur. J. Biochem. 22:203-12
8. Ochoa S. 1980. The pursuit of a hobby. Annu. Rev. Biochem. 49:1-30
9. Verkade PE, Elzas M, van der Lee J, de Wolff HH, Verkade-Sandbergen A, van der Sande D. 1932. Untersuchen über den fettstoffwechsel. Proc. K. Ned. Akad. Wet. 35:251-66
10. Den H. 1958. Biological omega oxidation. PhD thesis, Univ. Michigan, Ann Arbor
11. Baptist JN, Gholson RK, Coon MJ. 1963. Hydrocarbon oxidation by a bacterial enzyme system. I. Products of octane oxidation. Biochim. Biophys. Acta 69:40-47
12. Gholson RK, Baptist JN, Coon MJ. 1963. Hydrocarbon oxidation by a bacterial enzyme system. II. Cofactor requirements for octanol formation from octane. Biochemistry 2:1155-59
13. Kusunose M, Kusunose E, Coon MJ. 1964. Enzymatic ω-oxidation of fatty acids. U. Substrate specificity and other properties of the enzyme system. J. Biol. Chem. 239:2135-39
14. Peterson JA, Basu D, Coon MJ. 1966. Enzymatic ω-oxidation. I. Electron carriers in fatty acid and hydrocarbon hydroxylation. J. Biol. Chem. 241:5162-63
15. Peterson JA, Coon MJ. 1968. Enzymatic ω-oxidation. III. Purification and properties of rubredoxin, a component of the ω-hydroxylation system of Pseudomonas oleovorans. J. Biol. Chem. 243:329-34
16. Ueda T, Coon MJ. 1972. Enzymatic ω-oxidation. VII. Reduced diphosphopyridine nucleotide-rubredoxin reductase: properties and function as an electron carrier in ω-hydroxylation. J. Biol. Chem. 247:5010-16
17. Ueda T, Lode ET, Coon MJ. 1972. Enzymatic ω-oxidation. VI. Isolation of homogeneous reduced diphosphopyridine nucleotide-rubredoxin reductase. J. Biol. Chem. 247:2109-15
18. McKenna EJ, Coon MJ. 1970. Enzymatic ω-oxidation. IV. Purification and properties of the ω-hydroxylase of Pseudomonas oleovorans. J. Biol. Chem. 245:3882-89
19. Ruettinger RT, Olson ST, Boyer RF, Coon MJ. 1974. Identification of the ω-hydroxylase of Pseudomonas oleovorans as a nonheme iron protein requiring phospholipid for catalytic activity. Biochem. Biophys. Res. Commun. 57:1011-17
20. Shanklin J, Achim C, Schmidt H, Fox GB, Munck E. 1997. Mossbauer studies of alkane omega-hydroxylases: evidence for a diiron cluster in an integral-membrane enzyme. Proc. Natl. Acad. Sci. USA 94:2981-86
21. Lu AYH, Coon MJ. 1968. Role of hemoprotein P450 in fatty acid ω-hydroxylation in a soluble enzyme system from liver microsomes. J. Biol. Chem. 243:1331-32
22. Lu AYH, Junk KW, Coon MJ. 1969. Resolution of the cytochrome P-450-containing ω-hydroxylation system of liver microsomes into three components. J. Biol. Chem. 244:3714-21
23. Strobel HW, Lu AYH, Heidema J, Coon MJ. 1970. Phosphatidylcholine requirement in the enzymatic reduction of hemoprotein P-450 and in fatty acid, hydrocarbon, and drug hydroxylation. J. Biol. Chem. 245:4851-54
24. Lu AYH, Strobel HW, Coon MJ. 1969. Hydroxylation of benzphetamine and other drugs by a solubilized form of cytochrome P-450 from liver microsomes: lipid requirement for drug demethylation. Biochem. Biophys. Res. Commun. 36: 545-51
25. Kaschnitz RM, Coon MJ. 1975. Drug and fatty acid hydroxylation by solubilized human liver microsomal cytochrome P-450-phospholipid requirement. Biochem. Pharmacol. 24:295-97
26. Duppel W, Lebeault JM, Coon MJ. 1973. Properties of a yeast cytochrome P-450-containing enzyme system which catalyzes the hydroxylation of fatty acids, alkanes, and drugs. Eur. J. Biochem. 36: 583-92
27. Ryan KJ, Engel LL. 1957. Hydroxylation of steroids at carbon 21. J. Biol. Chem. 225:103-14
28. Klingenberg M. 1958. Pigments of rat liver microsomes. Arch. Biochem. Biophys. 75:376-86
29. Garfinkel D. 1958. Studies on pig liver microsomes. I. Enzymic and pigment composition of different microsomal fractions. Arch. Biochem. Biophys. 77:493-509
30. Omura T, Sato R. 1962. A new cytochrome in liver microsomes. J. Biol. Chem. 237:PC1375-76
31. Omura T, Sato R, Cooper DY, Rosenthal O, Estabrook RW. 1965. Function of cytochrome P-450 of microsomes. Federation Proc. 24:1181-89
32. Lu AYH. 1998. The Bernard B. Brodie lecture. A journey in cytochrome P450 and drug metabolism research. Drug Metab. Dispos. 26:1168-73
33. Gillette JR, Conney AH, Cosmides GJ, Estabrook RW, Fouts JR, Mannering GJ, eds. 1969. Microsomes and Drug Oxidations. New York: Academic. 547 pp.
34. Coon MJ, Lu AYH. 1969. Fatty acid ω-oxidation in a soluble microsomal enzyme system containing P-450. See Ref. 33, pp. 151-66
35. Gunsalus IC, Sligar SG. 1978. Oxygen reduction by the P450 monooxygenase systems. Adv. Enzyme Regul. 47:1-44
36. Coon MJ, Sligar SG. 2003. Irwin C. Gunsalus, talented and creative scientist. Biochem. Biophys. Res. Commun. 312:1-6
37. Ruckpaul K. 2003. Early years of cytochrome P450 research in Berlin-Buch: its present state and origin of the biochemical and biophysical conferences. Biochem. Biophys. Res. Commun. 312:65-74
38. Maricic S. 1977. Foreward to proceedings of the Scientific Conference on Cytochrome P-450-structural aspects (Primosten, Yugoslavia), ed. MJ Coon, IC Gunsalus, S Maricic. Croat. Chem. Acta 49:163-388
39. Conney AH. 2003. Induction of drug-metabolizing enzymes: a path to the discovery of multiple cytochromes P450. Annu. Rev. Pharmacol. Toxicol. 43:1-30
40. Nebert DW, Heidema JK, Strobel HW, Coon MJ. 1973. Genetic expression of aryl hydrocarbon hydroxylase induction. Genetic specificity resides in the fraction containing cytochrome P448 and P450. J. Biol. Chem. 248:7631-36
41. Lu AYH, Kuntzman R, West S, Conney AH. 1972. Reconstituted liver microsomal enzyme system that hydroxylates drugs, other foreign compounds, and endogenous substrates. I. Determination of substrate specificity by the cytochrome P-450 and P-448 fractions. Biochem. Biophys. Res. Commun. 42:1200-6
42. Autor AP, Kaschnitz RM, Heidema JK, Coon MJ. 1973. Sedimentation and other properties of the reconstituted liver microsomal mixed-function oxidase system containing cytochrome P450, reduced triphosphopyridine nucleotide-cytochrome P450 reductase, and phosphatidylcholine. Mol. Pharmacol. 9:93-104
43. Coon MJ, van der Hoeven TA, Kaschnitz RM, Strobel HW 1973. Biochemical studies on cytochrome P-450 solubilized from liver microsomes: partial purification and mechanism of catalysis. Ann. NY Acad. Sci. 212:449-57
44. van der Hoeven TA, Coon MJ. 1974. Preparation and properties of partially purified cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase from rabbit liver microsomes. J. Biol. Chem. 249:6302-10
45. Haugen DA, van der Hoeven TA, Coon MJ. 1975. Purified liver microsomal cytochrome P-450. Separation and characterization of multiple forms. J. Biol. Chem. 250:3567-70
46. Haugen DA, Coon MJ. 1976. Properties of electrophoretically homogeneous phenobarbital-inducible and β-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J. Biol. Chem. 251:7929-39
47. Nebert DW, Adesnik M, Coon MJ, Estabrook RW, Gonzalez FJ, et al. 1987. The P450 gene superfamily: recommended nomenclature. DNA 6:1-11
48. 4. J. Biol. Chem. 252:3255-61
49. LM. FEBS Lett. 116:231-35
50. Chiang YL, Coon MJ. 1979. Comparative study of two highly purified forms of liver microsomal cytochrome P-450: circular dichroism and other properties. Arch. Biochem. Biophys. 195:178-87
51. Inouye K, Coon MJ. 1985. Properties of the tryptophan residue in rabbit liver microsomal cytochrome P-450 isozyme 2 as determined by fluorescence. Biochem. Biophys. Res. Commun. 128:676-82
52. Haugen DA, Coon MJ, Nebert DW 1976. Induction of multiple forms of mouse liver cytochrome P-450. Evidence for genetically controlled de novo protein synthesis in response to treatment with β-naphthoflavone or phenobarbital. J. Biol. Chem. 251:1817-27
53. Zaphiropoulos PG, Folk WR, Coon MJ. 1986. Isolation and characterization of a novel cytochrome P-450-like pseudogene. Biochem. Biophys. Res. Commun. 134:499-505
54. Haugen DA, Armes LG, Yasunobu KT, Coon MJ. 1977. Amino-terminal sequence of phenobarbital-inducible cytochrome P-450 from rabbit liver microsomes: similarity to hydrophobic aminoterminal segments of preproteins. Biochem. Biophys. Res. Commun. 77: 967-73
55. Tarr GE, Black SD, Fujita VS, Coon MJ. 1983. Complete amino acid sequence and predicted membrane topology of phenobarbital-induced cytochrome P-450 (isozyme 2) from rabbit liver microsomes. Proc. Natl. Acad. Sci. USA 80:6552-56
56. Fujita VS, Black SD, Tarr GE, Koop DR, Coon MJ. 1984. On the amino acid sequence of cytochrome P-450 isozyme 4 from rabbit liver microsomes. Proc. Natl. Acad. Sci. USA 81:4260-64
57. Vermilion JL, Coon MJ. 1974. Highly purified detergent-solubilized NADPH-cytochrome P-450 reductase from phenobarbital-induced rat liver microsomes. Biochem. Biophys. Res. Commun. 60: 1315-22
58. French JS, Coon MJ. 1979. Properties of NADPH-cytochrome P-450 reductase purified from rabbit liver microsomes. Arch. Biochem. Biophys. 195:565-77
59. Black SD, Coon MJ. 1982. Structural features of liver microsomal NADPH-cytochrome P-450 reductase. Hydrophobic domain, hydrophilic domain, and connecting region. J. Biol. Chem. 257:5929-38
60. Wang M, Roberts DL, Paschke R, Shea TM, Masters BSS, Kim J-JP. 1997. Three-dimensional structure of NADPH-cytochrome P450 reductase: prototype for FMN- and FAD-containing enzymes. Proc. Natl. Acad. Sci. USA 94:8411-16
61. French JS, Guengerich FP, Coon MJ. 1980. Interactions of cytochrome P-450, NADPH-cytochrome P-450 reductase, phospholipids, and substrate in the reconstituted liver microsomal enzyme system. J. Biol. Chem. 255:4112-19
62. Ruckpaul K, Rein H, Ballou DP, Coon MJ. 1980. Analysis of interactions among purified components of the liver microsomal cytochrome P-450-containing monooxygenase system by second derivative spectroscopy. Biochim. Biophys. Acta 626:41-56
63. 5. J. Biol. Chem. 257:11221-29
64. 5. Drug Metab. Dispos. 12:358-64
65. 5. J. Biol. Chem. 259:15377-85
66. 5 on the formation of products in cytochrome P-450-catalyzed reactions. Drug Metab. Dispos. 14:89-96
67. LM3b, a constitutive form of cytochrome P-450, from rabbit liver microsomes. Biochem. Biophys. Res. Commun. 91:1075-81
68. Koop DR, Persson AV, Coon MJ. 1981. Properties of electrophoretically homogeneous, constitutive forms of liver microsomal cytochrome P-450. J. Biol. Chem. 256:10704-11
69. Koop DR, Coon MJ. 1984. Purification of liver microsomal cytochrome P-450 isozymes 3a and 6 from imidazole-treated rabbits. Evidence for the identity of isozyme 3a with the form obtained by ethanol treatment. Mol. Pharmacol. 25:494-501
70. Ishida H, Noshiro M, Okuda K, Coon MJ. 1992. Purification and characterization of 7α-hydroxy-4-cholesten-3-one 12α-hydroxylase. J. Biol. Chem. 267:21319-23
71. Koop DR, Morgan ET, Tarr GE, Coon MJ. 1982. Purification and characterization of a unique isozyme of cytochrome P-450 from liver microsomes of ethanol-treated rabbits. J. Biol. Chem. 257:8472-80
72. Morgan ET, Koop DR, Coon MJ. 1982. Catalytic activity of cytochrome P-450 isozyme 3a isolated from liver microsomes of ethanol-treated rabbits. J. Biol. Chem. 257:13951-57
73. Lieber CS, DeCarli LM. 1968. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 162:917-18
74. Koop DR, Coon MJ. 1986. Ethanol oxidation and toxicity: role of alcohol P-450 oxygenase. Alcohol. Clin. Exp. Res. 10:44S-49
75. Morgan ET, Koop DR, Coon MJ. 1983. Comparison of six rabbit liver cytochrome P-450 isozymes in formation of a reactive metabolite of acetaminophen. Biochem. Biophys. Res. Commun. 112:8-13
76. Coon MJ, Roberts ES, Vaz ADN. 1991. Predominant role of alcohol-inducible P-450s in oxidative damage. In Oxidative Damage and Repair: Chemical, Biological and Medical Aspects, ed. KJA Davies, pp. 726-31. New York: Pergamon
77. Yang CS, Tu YY, Koop DR, Coon MJ. 1985. Metabolism of nitrosamines by purified rabbit liver cytochrome P-450 isozymes. Cancer Res. 45:1140-45
78. Ingelman-Sundberg M, Johansson I, Pentillä KE, Glaumann H, Lindros KO. 1988. Centrilobular expression of ethanol-inducible cytochrome P-450 (IIE1) in rat liver. Biochem. Biophys. Res. Commun. 157:55-60
79. Vaz ADN, Roberts ES, Coon MJ. 1990. Reductive β-scission of the hydroperoxides of fatty acids and xenobiotics: role of alcohol-inducible cytochrome P-450. Proc. Natl. Acad. Sci. USA 87:5499-5503
80. Khani SC, Porter TD, Fujita VS, Coon MJ. 1988. Organization and differential expression of two highly similar genes in the rabbit alcohol-inducible cytochrome P-450 subfamily. J. Biol. Chem. 263:7170-75
81. Porter TD, Khani SC, Coon MJ. 1989. Induction and tissue-specific expression of rabbit cytochrome P450IIE1 and IIE2 genes. Mol. Pharmacol. 36:61-65
82. Peng H-M, Coon MJ. 1998. Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone. Mol. Pharmacol. 54:740-47
83. Peng H-M, Coon MJ. 2000. Promoter function and the role of cytokines in the transcriptional regulation of rabbit CYP2E1 and CYP2E2. Arch. Biochem. Biophys. 382:129-37
84. Porter TD. 2004. Jud Coon: 35 years of P450 research. A synopsis of P450 history. Drug Metab. Dispos. 32:1-6
85. Barnes HJ, Arlotto MP, Waterman MR. 1991. Expression and enzymatic activity of recombinant cytochrome P450 17 alpha-hydroxylase in Escherichia coli. Proc. Natl. Acad. Sci. USA 88:5597-601
86. 2-terminal membrane-insertion signal peptide does not alter the catalytic activites. Proc. Natl. Acad. Sci. USA 88:9141-45
87. 2-terminal region and expressed in Escherichia coli. Arch. Biochem. Biophys. 318:446-56
88. Ding X, Coon MJ. 1988. Purification and characterization of two unique forms of cytochrome P-450 from rabbit nasal microsomes. Biochemistry 27:8330-37
89. Peng H-M, Ding X, Coon MJ. 1993. Isolation and heterologous expression of cloned cDNAs for two rabbit nasal microsomal proteins, CYP 2A10 and CYP 2A11, that are related to nasal cytochrome P450 form a. J. Biol. Chem. 268:17253-60
90. Ding X, Porter TD, Peng H-M, Coon MJ. 1991. cDNA and derived amino acid sequence of rabbit nasal cytochrome P-450NMb (P-450IIG1), a unique isozyme possibly involved in olfaction. Arch. Biochem. Biophys. 285:120-25
91. Ding X, Kaminsky LS. 2003. Human extrahepatic cytochromes P450: function in xenobiotic metabolism and tissue-selective chemical toxicity in the respiratory and gastrointestinal tracts. Annu. Rev. Pharmacol. Toxicol. 43:149-73
92. Lu AYH, West SB. 1980. Multiplicity of mammalian microsomal cytochrome P-450s. Pharmacol. Rev. 31:277-95
93. Nelson DR. 1999. Cytochrome P450 and the individuality of species. Arch. Biochem. Biophys. 369:1-10
94. Vermilion JL, Ballou DP, Massey V, Coon MJ. 1981. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase. J. Biol. Chem. 256:266-77
95. Oprian DD, Coon MJ. 1982. Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH. J. Biol. Chem. 257:8935-44
96. Coon MJ, Ding X, Pernecky SJ, Vaz ADN. 1992. Cytochrome P450: progress and predictions. FASEB J. 6:669-73
97. Olson JS, Ballou DP, Palmer G, Massey V. 1974. The mechanism of action of xanthine oxidase. 1974. J. Biol. Chem. 249:4363-82
98. White RE, Coon MJ. 1980. Oxygen activation by cytochrome P-450. Annu. Rev. Biochem. 49:315-56
99. Groves JT, McClusky GA, White RE, Coon MJ. 1978. Aliphatic hydroxylation by highly purified liver microsomal cytochrome P-450. Evidence for a carbon radical intermediate. Biochem. Biophys. Res. Commun. 81:154-60
100. Vaz ADN, Roberts ES, Coon MJ. 1990. Reductive β-scission of the hydroperoxides of fatty acids and xenobiotics: role of alcohol-inducible cytochrome P-450. Proc. Natl. Acad. Sci. USA 87:5499-503
101. Roberts ES, Vaz ADN, Coon MJ. 1991. Catalysis by cytochrome P-450 of an oxidative reaction in xenobiotic aldehyde metabolism: deformylation with olefin formation. Proc. Natl. Acad. Sci. USA 88:8963-66
102. Akhtar M, Calder MR, Corina DL, Wright JN. 1982. Mechanistic studies on C-19 demethylation in oestrogen biosynthesis. Biochem. J. 201:569-80
103. Vatsis KP, Coon MJ. 2002. Ipso-substitution by cytochrome P450 with conversion of p-hydroxybenzene derivatives to hydroquinone: evidence for hydroperoxo-iron as the active oxygen species. Arch. Biochem. Biophys. 397:119-29
104. Guengerich FP. 2001. Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. Chem. Res. Toxicol. 14:611-50
105. Fasco MJ, Vatsis KP, Kaminsky LS, Coon MJ. 1978. Regioselective and stereoselective hydroxylation of R and S warfarin by different forms of purified cytochrome P-450 from rabbit liver. J. Biol. Chem. 253:7813-20
106. Deutsch J, Vatsis KP, Coon MJ, Leutz JC, Gelboin HV 1979. Catalytic activity and stereoselectivity of purified forms of rabbit liver microsomal cytochrome P-450 in the oxygenation of the (-) and (+) enantiomers of trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene. Mol. Pharmacol. 16:1011-18
107. Gorsky LD, Koop DR, Coon MJ. 1984. On the stoichiometry of the oxidase and monooxygenase reactions catalyzed by liver microsomal cytochrome P-450. Products of oxygen reduction. J. Biol. Chem. 259:6812-17
108. Nordblom GD, White RE, Coon MJ. 1976. Studies on hydroperoxide-dependent substrate hydroxylation by purified liver microsomal cytochrome P-450. Arch. Biochem. Biophys. 175:524-33
109. Ellin A, Orrenius S. 1975. Hydroperoxide-supported cytochrome P-450-linked fatty acid hydroxylation in liver microsomes. FEBS Lett. 50:378-81
110. Blake RC II, Coon MJ. 1981. On the mechanism of action of cytochrome P-450. Evaluation of homolytic and heterolytic mechanisms of oxygen-oxygen bond cleavage during substrate hydroxylation by peroxides. J. Biol. Chem. 256:12127-33
111. Blake RC II, Coon MJ. 1989. On the mechanism of action of cytochrome P-450. Spectral intermediates in the reaction with iodosobenzene and its derivatives. J. Biol. Chem. 264:3694-701
112. Osawa Y, Coon MJ. 1989. Selective mechanism-based inactivation of the major phenobarbital-inducible cytochrome P-450 from rabbit liver by phencyclidine and its oxidation product, the iminium compound. Drug Metab. Dispos. 17:7-13
113. Vaz ADN, Kessell KJ, Coon MJ. 1994. Aromatization of a bicyclic steroid analog, 3-oxodecalin-4-ene-10-carboxaldehyde, by liver microsomal cytochrome P450 2B4. Biochemistry 33: 13651-61
114. Vaz ADN, Coon MJ, Peegel H, Menon KMJ. 1992. Substituted pyridines: non-steroidal inhibitors of human placental aromatase cytochrome P450. Drug Metab. Dispos. 20:108-12
115. Vaz ADN, Pernecky SJ, Raner GM, Coon MJ. 1996. Peroxo-iron and oxenoid-iron species as alternative oxygenating agents in cytochrome P450-catalyzed reactions: switching by T302A mutagenesis of cytochrome P450 2B4. Proc. Natl. Acad. Sci. USA 93:4644-48
116. Vaz ADN, McGinnity DF, Coon MJ. 1998. Epoxidation of olefins by cytochrome P450: evidence from site-specific mutagenesis for hydroperoxo-iron as an electrophilic oxidant. Proc. Natl. Acad. Sci. USA 95:3555-60
117. Imai M, Shimada H, Watanabe Y, Matsushima-Hibiya Y, Makino R, et al. 1989. Uncoupling of the cytochrome P-450cam monooxygenase reaction by a single mutation, threonine-252 to alanine or valine: a possible role of the hydroxy amino acid in oxygen activation. Proc. Natl. Acad. Sci. USA 86:7823-27
118. Martinis SA, Atkins WM, Stayton PS, Sligar SG. 1989. A conserved residue of cytochrome P-450 is involved in heme-oxygen stability and activation. J. Am. Chem. Soc. 111:9252-53
119. Vatsis KP, Peng H-M, Coon MJ. 2002. Replacement of active-site cysteine-436 by serine converts cytochrome P450 2B4 into an NADPH oxidase with negligible monooxygenase activity. J. Inorg. Biochem. 91:542-43
120. Coon MJ, Vaz ADN, McGinnity DF, Peng H-M. 1998. Multiple activated oxygen species in P450 catalysis: contributions to specificity in drug metabolism. Drug Metab. Dispos. 26:1190-93
121. Newcomb M, Hollenberg PF, Coon MJ. 2003. Multiple mechanisms and multiple oxidants in P450-catalyzed hydroxylations. Arch. Biochem. Biophys. 409:72-79
122. Newcomb M, Shen R, Choi S-Y, Hollenberg PF, Vaz ADN, Coon MJ. 2000. Cytochrome P450-catalyzed hydroxylation of mechanistic probes that distinguish between radicals and cations. Evidence for cationic but not for radical intermediates. J. Am. Chem. Soc. 122:2677-86
123. Shaik S, Filatov M, Schroder D, Schwarz H. 1998. Electronic structure makes a difference: cytochrome P450 mediated hydroxylations of hydrocarbons as a two-state reactivity paradigm. Chem. Eur. J. 4:193-99
124. Yoshizawa K, Kamachi T, Shiota Y. 2001. A theoretical study of the dynamic behavior of alkane hydroxylation by a compound I model of cytochrome P450. J. Am. Chem. Soc. 123:9806-16
125. Ullrich V, Staudinger H. 1968. Aktiviering von sauerstoff in modellsystemen. In Nineteenth Colloquium des Gesellschaft fur Biologische Chemie: Biochemie des Sauerstoffs, ed. B Hass, H Staudinger, pp. 229-48. Berlin: Springer
126. Hamilton GA. 1974. Chemical models and mechanisms for oxygenases. In Molecular Mechanisms of Oxygen Activation, ed. O Hayaishi, pp. 405-51. New York: Academic
127. Cosme J, Johnson EF. 2000. Engineering microsomal cytochrome P450 2C5 to be a soluble, monomeric enzyme. Mutations that alter aggregation, phospholipids dependence of catalysis and membrane binding. J. Biol. Chem. 275:2545-53
128. Williams PA, Cosme J, Sridhar V, Johnson EF, McRee DE. Mammalian microsomal cytochrome P450 monooxygenase: structural adaptations for membrane binding and functional diversity. Mol. Cell 5:121-31
129. Scott EE, He YA, Wester MR, White MA, Chin CC, et al. 2003. An open conformation of mammalian cytochrome P450 2B4 at 1.6 Å resolution. Proc. Natl. Acad. Sci. USA 100:13196-201